Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03856788 · ClinicalTrials.gov registry record · Phase 4
Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery
A Phase 4 study of Laparoscopic Sleeve Gastrectomy and Subcostal Transversus Abdominis Plane Block, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03856788 is a Phase 4 study of Laparoscopic Sleeve Gastrectomy and Subcostal Transversus Abdominis Plane Block that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03856788, a Phase 4 study of Laparoscopic Sleeve Gastrectomy and Subcostal Transversus Abdominis Plane Block, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will be assessing if the unilateral subcostal transversus abdominis plane (TAP) block can decrease pain and improve outcomes following laparoscopic sleeve gastrectomy surgeries.
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Saline
Study Locations (1)
New York
- Mount Sinai Brooklyn - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-12-10 |
| Est. Completion | 2021-03-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03856788
The ClinicalTrials.gov registry entry for NCT03856788 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Laparoscopic Sleeve Gastrectomy appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03856788 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03856788 about?
NCT03856788 is a clinical study titled "Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery". The study team will be assessing if the unilateral subcostal transversus abdominis plane (TAP) block can decrease pain and improve outcomes following laparoscopic sleeve gastrectomy surgeries.
What is the current status of trial NCT03856788?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2018-12-10. Estimated completion is 2021-03-25.
What conditions does trial NCT03856788 study?
This clinical trial studies the following conditions: Laparoscopic Sleeve Gastrectomy, Subcostal Transversus Abdominis Plane Block.
What interventions are being tested in trial NCT03856788?
The interventions under investigation include: Bupivacaine (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT03856788?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03856788 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laparoscopic Sleeve Gastrectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Laparoscopic Sleeve Gastrectomy
All registered trials for this condition
Subcostal Transversus Abdominis Plane Block
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.